Health4 sources
New federal rule mandates drug intermediaries to disclose payment details
- The Department of Labor released a final rule requiring pharmacy benefit managers (PBMs) to disclose payment details.
- PBMs manage billions of dollars in prescription drug spending for employers and workers.
- The rule aims to unlock highly protected data on fees and compensation from drugmakers.
- The regulation is a significant move to increase transparency in prescription drug spending.
- The rule was finalized by the Trump administration.
Timeline
Exclusive: Drug Middlemen to Share Payment Details
A new federal rule will require prescription drug middlemen to disclose payment data.
Trump Administration Rule on Drug Middlemen Payments
The Trump administration will mandate drug middlemen to disclose their payment methods.
Latest
New Federal Rule on Drug Intermediaries Payments
A new federal rule requires companies managing prescription drug spending to disclose their payment methods.
Articles (4)
The Hill·
New federal rule requires drug intermediaries to disclose how they're paid
The Washington Post·
Trump administration will require drug middlemen to disclose how much they are paid
STAT·
STAT+: New federal rule will require prescription drug middlemen to share secret payments data
The Wall Street Journal·
Exclusive | Drug Middlemen Will Soon Have to Share Details on How They Are Paid